Acute deep vein thrombosis of lower limbs treated by thrombolytic therapy with recombinant tissue-type plasminogen activator
Wu, J.-d.; Guan, H.; Wang, S.-h.; Liu, C.-w.; Jin, Y.-f.; Liu, B.; Ye, W.; Zeng, R.
Zhonghua Yi Xue Za Zhi 85(7): 491-492
2005
ISSN/ISBN: 0376-2491 PMID: 15854559 Document Number: 593173
Document emailed within 1 workday
Related Documents
Nelles, L.; Lijnen, H.R.; Van Nuffelen, A.; Demarsin, E.; Collen, D. 1990: Characterization of domain deletion and/or duplication mutants of a recombinant chimera of tissue-type plasminogen activator and urokinase-type plasminogen activator (rt-PA/u-PA) Thrombosis and Haemostasis 64(1): 53-60Mannuccio Mannucci, P.; Altieri, D.; Mari, D. 1987: Thrombolytic therapy in acute deep venous thrombosis of the lower limbs: selection, indications and limits Minerva Chirurgica 42(23-24): 2031-2035
Menon, I.S. 1972: The muscle as a possible source of plasminogen activator to the blood and their therapeutic implication in the prevention of deep vein thrombosis Acta Universitatis Carolinae. Medica. Monographia 52: 181-184
Carreras, L.O. 1985: Selective thrombolytic therapy with a tissue activator of plasminogen Medicina 45(3): 309-311
Fincke, U.; Schneider, J.; Friderichs, E.; Giertz, H.; Flohé, L. 1988: Enhanced myocardial salvage by combined treatment with recombinant single-chain urokinase-type plasminogen activator and recombinant human superoxide dismutase in a canine coronary thrombosis model Arzneimittel-Forschung 38(1): 138-142
Fujii, S.; Lucore, C.L.; Hopkins, W.E.; Billadello, J.J.; Sobel, B.E. 1990: Induction of synthesis of plasminogen activator inhibitor type-1 by tissue-type plasminogen activator in human hepatic and endothelial cells Thrombosis and Haemostasis 64(3): 412-419
Schermer, E.; Streif, W.; Genser, N.; Frühwirth, M.; Trawöger, R.; Simma, B. 2000: Thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in 13 children: a case series Wiener Klinische Wochenschrift 112(21): 927-933
Topol, E.J. 1989: Recombinant tissue plasminogen activator: implications in therapy Seminars in Hematology 26(3 Suppl 3: 25-31
Al-Buhairi, A.R.; Jan, M.M. 2002: Recombinant tissue plasminogen activator for acute ischemic stroke Saudi Medical Journal 23(1): 13-19
Al-Buhairi, A.R.; Jan, M.M. 2002: Recombinant tissue plasminogen activator for acute ischemic stroke Neurosciences 7(1): 7-13
Dodd, I.; Fears, R.; Robinson, J.H. 1986: Isolation and preliminary characterisation of active B-chain of recombinant tissue-type plasminogen activator Thrombosis and Haemostasis 55(1): 94-97
Han, X.M.; Chen, Z.Q.; Mao, H.M. 1990: Determination of plasma tissue type plasminogen activator and plasminogen activator inhibitor activity in patients with ischemic stroke Zhonghua Nei Ke Za Zhi 29(9): 544-546; 575-576
De Moerloose, P.; Mermillod, N.; Amiral, J.; Reber, G. 1998: Thrombomodulin levels during normal pregnancy, at delivery and in the postpartum: comparison with tissue-type plasminogen activator and plasminogen activator inhibitor-1 Thrombosis and Haemostasis 79(3): 554-556
Fukao, H.; Yamamoto, K.; Matsuo, O. 1991: Levels of tissue-type plasminogen activator and plasminogen activator inhibitor 1 in disseminated intravascular coagulation syndrome Rinsho Byori. Japanese Journal of Clinical Pathology 39(7): 720-726
Wallnöfer, A.E.; van Griensven, J.M.; Schoemaker, H.C.; Cohen, A.F.; Lambert, W.; Kluft, C.; Meijer, P.; Kooistra, T. 1993: Effect of isotretinoin on endogenous tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor 1 (PAI-1) in humans Thrombosis and Haemostasis 70(6): 1005-1008
Volgesang, G.B.; Bell, W.R. 1984: Treatment of pulmonary embolism and deep vein thrombosis with thrombolytic therapy Clinics in Chest Medicine 5(3): 487-494
Wilkes, N.P.; Magee, M.; Hoschl, R.; Nelson, G.I. 1990: Late (one month) reversible ischaemia after primary coronary occlusion treated with recombinant tissue plasminogen activator (rTPA) Australian and New Zealand Journal of Medicine 20(2): 149-153
Habib, S.S.; Abdel Gader, A.G.M.; Kurdi, M.I.; Suriya, M.O.; Al Aseri, Z. 2012: Tissue plasminogen activator and plasminogen activator inhibitor-1 levels in patients with acute myocardial infarction and unstable angina JPMA. Journal of the Pakistan Medical Association 62(7): 681-685
Wang, S.P.; Liu, C.P.; Charng, M.J.; Chou, C.Y.; Tsai, J.H.; Pan, J.P.; Shyong, W.C.; Chan, W.L.; Kong, C.W.; Chang, M.S. 1989: The efficacy and safety of recombinant tissue plasminogen activator infusion in acute myocardial infarction Zhonghua Yi Xue Za Zhi 43(4): 223-228
Silva, A.; Jais, J.M. 1994: Thrombosis of mechanical tricuspid valve prosthesis: treatment by tissue-type plasminogen activator. Success after a 18 month-follow-up Archives des Maladies du Coeur et des Vaisseaux 87(6): 813-817